Some treatments cause seizure aggravation in idiopathic epilepsies (especially absence epilepsy)

Epilepsia

Volumn 50, Issue SUPPL. 8, 2009, Pages 31-36

  Somerville, Ernest R ^a,b  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Adverse effect; Anticonvulsant; Epilepsy; Exacerbation; Paradoxical

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENYTOIN; PLACEBO; TIAGABINE; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE;

ABSENCE; ADD ON THERAPY; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISEASE EXACERBATION; EPILEPTIC STATE; FOCAL EPILEPSY; GENERALIZED EPILEPSY; HUMAN; LENNOX GASTAUT SYNDROME; MYOCLONUS EPILEPSY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEIZURE; THERAPY EFFECT;

ACUTE DISEASE; ANTICONVULSANTS; ELECTROENCEPHALOGRAPHY; EPILEPSY, ABSENCE; EPILEPSY, GENERALIZED; HUMANS; SEIZURES; SYNDROME; TREATMENT OUTCOME;

EID: 68949220931     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2009.02233.x     Document Type: Review

References (37)

1. Anhut H, Ashman P, Feuerstein TJ, Sauermann W, Saunders M, Schmidt B 1994) Gabapentin (Neurontin) as add-on therapy in patients with partial seizures: a double-blind, placebo-controlled study. The international gabapentin study group. Epilepsia 35 : 795 801.
2. Bauer J 1996) Seizure-inducing effects of antiepileptic drugs: a review. Acta Neurol Scand 94 : 367 377.
3. Berkovic SF 1998) Aggravation of generalized epilepsies. Epilepsia 39 (suppl 3 S11 14.
4. Berkovic SF, Knowlton RC, Leroy RF, Schiemann J, Falter U 2007) Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy. Neurology 69 : 1751 1760.
5. Chaves J, Sander JW 2005) Seizure aggravation in idiopathic generalized epilepsies. Epilepsia 46 (suppl 9 133 139.
6. Cramer JA, Fisher R, Ben-Menachem E, French J, Mattson RH 1999) New antiepileptic drugs: comparison of key clinical trials. Epilepsia 40 : 590 600.
7. Flowers CM, Racoosin JA, Kortepeter C 2006) Seizure activity and off-label use of tiagabine. N Engl J Med 354 : 773 774.
8. Gelisse P, Genton P, Kuate C, Pesenti A, Baldy-Moulinier M, Crespel A 2004) Worsening of seizures by oxcarbazepine in juvenile idiopathic generalized epilepsies. Epilepsia 45 : 1282 1286.
9. Genton P 2000) When antiepileptic drugs aggravate epilepsy. Brain Dev 22 : 75 80.
10. Genton P, Gelisse P, Thomas P, Dravet C 2000) Do carbamazepine and phenytoin aggravate juvenile myoclonic epilepsy? Neurology 55 : 1106 1109.
11. Guerrini R, Belmonte A, Genton P 1998a) Antiepileptic drug-induced worsening of seizures in children. Epilepsia 39 (suppl 3 S2 10.
12. Guerrini R, Dravet C, Genton P, Belmonte A, Kaminska A, Dulac O 1998b) Lamotrigine and seizure aggravation in severe myoclonic epilepsy. Epilepsia 39 : 508 512.
13. Horn CS, Ater SB, Hurst DL 1986) Carbamazepine-exacerbated epilepsy in children and adolescents. Pediatr Neurol 2 : 340 345.
14. Kazzi ZN, Jones CC, Morgan BW 2006) Seizures in a pediatric patient with a tiagabine overdose. J Med Toxicol 2 : 160 162.
15. Koepp MJ, Edwards M, Collins J, Farrel F, Smith S 2005) Status epilepticus and tiagabine therapy revisited. Epilepsia 46 : 1625 1632.
16. Liu L, Zheng T, Morris MJ, Wallengren C, Clarke AL, Reid CA, Petrou S, O'Brien TJ 2006) The mechanism of carbamazepine aggravation of absence seizures. J Pharmacol Exp Ther 319 : 790 798.
17. Marescaux C, Vergnes M, Depaulis A 1992) Genetic absence epilepsy in rats from Strasbourg - a review. J Neural Transm Suppl 35 : 37 69.
18. Marini C, Parmeggiani L, Masi G, D'arcangelo G, Guerrini R 2005) Nonconvulsive status epilepticus precipitated by carbamazepine presenting as dissociative and affective disorders in adolescents. J Child Neurol 20 : 693 696.
19. Matsuo F, Bergen D, Faught E, Messenheimer JA, Dren AT, Rudd GD, Lineberry CG 1993) Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures. U.S. lamotrigine protocol 05 clinical trial group. Neurology 43 : 2284 2291.
20. Noachtar S, Andermann E, Meyvisch P, Andermann F, Gough WB, Schiemann-Delgado J 2008) Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures. Neurology 70 : 607 616.
21. Perucca E, Gram L, Avanzini G, Dulac O 1998) Antiepileptic drugs as a cause of worsening seizures. Epilepsia 39 : 5 17.
22. Rheims S, Cucherat M, Arzimanoglou A, Ryvlin P 2008) Greater response to placebo in children than in adults: a systematic review and meta-analysis in drug-resistant partial epilepsy. PLoS Med 5 : e166.
23. Sazgar M, Bourgeois BF 2005) Aggravation of epilepsy by antiepileptic drugs. Pediatr Neurol 33 : 227 234.
24. Schmidt D 1998) Drug trials in epilepsy: a physicians' guide. Taylor & Francis, London.
25. Seymour JF 1993) Carbamazepine overdose. Features of 33 cases. Drug Saf 8 : 81 88.
26. So EL, Ruggles KH, Cascino GD, Ahmann PA, Weatherford KW 1994) Seizure exacerbation and status epilepticus related to carbamazepine-10,11-epoxide. Ann Neurol 35 : 743 746.
27. Somerville ER 2002) Aggravation of partial seizures by antiepileptic drugs: is there evidence from clinical trials? Neurology 59 : 79 83.
28. Somerville ER 2008) Lack of seizure aggravation by levetiracetam in idiopathic generalized epilepsy: evidence from clinical trials. Epilepsia 49 (suppl 7 S456 457.
29. Spiller HA, Winter ML, Ryan M, Krenzelok EP, Anderson DL, Thompson M, Kumar S 2005) Retrospective evaluation of tiagabine overdose. Clin Toxicol (Phila) 43 : 855 859.
30. Tassinari CA, Dravet C, Roger J, Cano JP, Gastaut H 1972) Tonic status epilepticus precipitated by intravenous benzodiazepine in five patients with Lennox-Gastaut syndrome. Epilepsia 13 : 421 435.
31. Trudeau V, Myers S, Lamoreaux L, Anhut H, Garofalo E, Ebersole J 1996) Gabapentin in naive childhood absence epilepsy: results from two double-blind, placebo-controlled, multicenter studies. J Child Neurol 11 : 470 475.
32. UK Gabapentin Study Group 1990) Gabapentin in partial epilepsy. Lancet 335 : 1114 1117.
33. US Food and Drug Administration 2009a) Depakote approved labeling. http://www.accessdata.fda.gov/drugsatfda-docs/label/2009/018723s039lbl.pdf. Accessed July 14, 2009.
34. US Food and Drug Administration. (2009b) Zonegran approved labeling. http://www.accessdata.fda.gov/drugsatfda-docs/label/2009/020789s022s025lbl.pdf. Accessed July 14, 2009.
35. Vendrame M, Khurana DS, Cruz M, Melvin J, Valencia I, Legido A, Kothare SV 2007) Aggravation of seizures and/or EEG features in children treated with oxcarbazepine monotherapy. Epilepsia 48 : 2116 2120.
36. Wallengren C, Li S, Morris MJ, Jupp B, O'Brien TJ 2005) Aggravation of absence seizures by carbamazepine in a genetic rat model does not induce neuronal c-Fos activation. Clin Neuropharmacol 28 : 60 65.
37. Zheng T, Clarke AL, Morris MJ, Reid CA, Petrou S, O'Brien TJ 2009) Oxcarbazepine, not its active metabolite, potentiates GABAA activation and aggravates absence seizures. Epilepsia 50 : 83 87.